Northstar Financial Companies, Inc. Astrazeneca PLC Transaction History
Northstar Financial Companies, Inc.
- $92.2 Billion
- Q1 2025
A detailed history of Northstar Financial Companies, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Northstar Financial Companies, Inc. holds 4,331 shares of AZN stock, worth $302,520. This represents 0.35% of its overall portfolio holdings.
Number of Shares
4,331
Previous 4,226
2.48%
Holding current value
$302,520
Previous $277 Million
14.96%
% of portfolio
0.35%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.99 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.84 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.49 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.22 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.19 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...